Data for: A comparison of DFO and DFO* conjugated to trastuzumab-DM1 for complexing 89Zr – MicroPET/CT imaging in NOD/SCID mice with HER2-positive SK-OV-3 human ovarian cancer xenografts

Published: 12-01-2020| Version 1 | DOI: 10.17632/5cbsywdybr.1
Contributors:
Raymond Reilly,
Mitchell Winnik,
Noor Al-saden,
Hyungjun Cho,
Heather Lam,
Juri Möbus

Description

Supporting Information for: Cho H, Al-saden N, Lam H, Mobus J, Reilly RM, Winnik MA. A comparison of DFO and DFO* conjugated to trastuzumab-DM1 for complexing 89Zr – In vitro stability and in vivo microPET/CT imaging studies in NOD/SCID mice with HER2-positive SK-OV-3 human ovarian cancer xenografts. Nucl. Med. Biol. (submitted) September 18, 2019.

Files